Lakefront Biotherapeutics NV LKFT
33.34 USD -0.07 (-0.21%)
At closeNov 12, 2026, 4:00 AM EST
34.49 +1.15 +3.45%
Pre-market · Nov 12, 4:00 AM ET
32.99 Day range 33.42
25.68 52-week range 36.24
- YTD
- +1.96%
- 1 year
- +3.19%
News
benzinga.com Lakefront Biotherapeutics Q3 EPS €(0.04) Beats €(0.19) Estimate, Sales €7.569M Miss €8.680M Estimate Lakefront Biotherapeutics (NASDAQ:LKFT) reported quarterly losses of €(0.04) per share which beat the analyst consensus estimate of €(0.19) by 78.95 percent. This is a 98.7 percent increase over…
globenewswire.com Lakefront Biotherapeutics Reports Nine Months 2026 Financial Results and Provides Business Update Gamgertamig poster accepted for presentation at the 2026 ASH 1 Annual Meeting, featuring data from ongoing Phase 1b studies that suggest potential to retain remission after B cell reconstitution,…
globenewswire.com Lakefront to Present at the 2026 Jefferies Global Healthcare Conference in London Mechelen, Belgium; November 10, 2026, 22.01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that the Company will host a fireside chat at the 2026 Jefferies Global…
benzinga.com Vylor, Franco-Nevada On Deck Wednesday As New Coverage, Gold Prices Face Test Vylor headlines Wednesday’s reports as investors assess how the newly covered consumer-staples company will be received, while Franco-Nevada offers a read on precious-metals exposure after a strong…
zacks.com Should You Buy Lakefront Biotherapeutics - Sponsored ADR (LKFT) After Golden Cross? Lakefront Biotherapeutics - Sponsored ADR (LKFT) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, LKFT's 50-day simple moving…